Compare Axon Enterprise Inc (AXON) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axon Enterprise Inc vs Neurocrine Biosciences Inc — how do they compare? Axon Enterprise Inc trades at $619.45 (market cap $51.69B), while Neurocrine Biosciences Inc trades at $158.83 (market cap $16.46B). The key difference: Axon Enterprise Inc is far larger — about 3.1× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.
| AXON | NBIX | |
|---|---|---|
Market Cap | $51.69B | $16.46B |
Sector | Technology | Health |
52-Week High | $791.62 | $185.50 |
52-Week Low | $345.94 | $123.10 |
Enterprise Value | $52.83B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axon Enterprise Inc
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
